Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125432911 | 12543291 | 1 | I | 20160204 | 20160705 | 20160711 | 20160711 | EXP | US-ROCHE-1789921 | ROCHE | 0.00 | E | M | Y | 113.50000 | KG | 20160711 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125432911 | 12543291 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Unknown | 125156 | |||||||||||
| 125432911 | 12543291 | 2 | SS | EYLEA | AFLIBERCEPT | 1 | Other | DATE OF LAST DOSE PRIOR TO EVENT- 22/FEB/2016 | 0 | 2 | MG | /month | |||||||
| 125432911 | 12543291 | 3 | SS | EYLEA | AFLIBERCEPT | 1 | Other | DATE OF LAST DOSE PRIOR TO EVENT- 22/FEB/2016 | 0 | 2 | MG | /month | |||||||
| 125432911 | 12543291 | 4 | SS | EYLEA | AFLIBERCEPT | 1 | Other | DATE OF LAST DOSE PRIOR TO EVENT- 22/FEB/2016 | 0 | 2 | MG | /month | |||||||
| 125432911 | 12543291 | 5 | SS | EYLEA | AFLIBERCEPT | 1 | Other | DATE OF LAST DOSE PRIOR TO EVENT- 22/FEB/2016 | 0 | 2 | MG | /month | |||||||
| 125432911 | 12543291 | 6 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | TABLET | ||||||||||
| 125432911 | 12543291 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 125432911 | 12543291 | 8 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 0 | ||||||||||||
| 125432911 | 12543291 | 9 | C | QUINAPRIL. | QUINAPRIL | 1 | 0 | ||||||||||||
| 125432911 | 12543291 | 10 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | 0 | ||||||||||||
| 125432911 | 12543291 | 11 | C | FINASTERIDE. | FINASTERIDE | 1 | 0 | ||||||||||||
| 125432911 | 12543291 | 12 | C | OXYGEN. | OXYGEN | 1 | 0 | ||||||||||||
| 125432911 | 12543291 | 13 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
| 125432911 | 12543291 | 14 | C | NAPROXEN SODIUM. | NAPROXEN SODIUM | 1 | Unknown | 0 | |||||||||||
| 125432911 | 12543291 | 15 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 125432911 | 12543291 | 16 | C | ACCUPRIL | QUINAPRIL HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125432911 | 12543291 | 1 | Diabetic retinal oedema |
| 125432911 | 12543291 | 2 | Diabetic retinal oedema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125432911 | 12543291 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125432911 | 12543291 | Cataract | |
| 125432911 | 12543291 | Drug ineffective | |
| 125432911 | 12543291 | Eye pain | |
| 125432911 | 12543291 | Pulmonary mass | |
| 125432911 | 12543291 | Visual acuity reduced | |
| 125432911 | 12543291 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125432911 | 12543291 | 1 | 20120516 | 0 | ||
| 125432911 | 12543291 | 2 | 20160119 | 0 | ||
| 125432911 | 12543291 | 3 | 20160222 | 0 | ||
| 125432911 | 12543291 | 4 | 20160229 | 0 | ||
| 125432911 | 12543291 | 5 | 20160125 | 0 |